Cargando…
Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age
Recent guidelines restricted aspirin (ASA) in primary prevention of cardiovascular disease (CVD) to patients <70 years old and more recent guidance to <60. In the most comprehensive prior meta-analysis, the Antithrombotic Trialists Collaboration reported a significant 12% reduction in CVD with...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710906/ https://www.ncbi.nlm.nih.gov/pubmed/34952844 http://dx.doi.org/10.1136/fmch-2021-001475 |
_version_ | 1784623264896647168 |
---|---|
author | Kim, Kyungmann Hennekens, Charles H Martinez, Lisa Gaziano, J Michael Pfeffer, Marc A Biglione, Bianca Gitin, Alexander McCabe, Jeanne Bell Cook, Thomas D DeMets, David L Wood, Sarah K |
author_facet | Kim, Kyungmann Hennekens, Charles H Martinez, Lisa Gaziano, J Michael Pfeffer, Marc A Biglione, Bianca Gitin, Alexander McCabe, Jeanne Bell Cook, Thomas D DeMets, David L Wood, Sarah K |
author_sort | Kim, Kyungmann |
collection | PubMed |
description | Recent guidelines restricted aspirin (ASA) in primary prevention of cardiovascular disease (CVD) to patients <70 years old and more recent guidance to <60. In the most comprehensive prior meta-analysis, the Antithrombotic Trialists Collaboration reported a significant 12% reduction in CVD with similar benefit−risk ratios at older ages. Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, four trials were added to an updated meta-analysis. ASA produced a statistically significant 13% reduction in CVD with 95% confidence limits (0.83 to 0.92) with similar benefits at older ages in each of the trials. Primary care providers should make individual decisions whether to prescribe ASA based on benefit−risk ratio, not simply age. When the absolute risk of CVD is >10%, benefits of ASA will generally outweigh risks of significant bleeding. ASA should be considered only after implementation of therapeutic lifestyle changes and other drugs of proven benefit such as statins, which are, at the very least, additive to ASA. Our perspective is that individual clinical judgements by primary care providers about prescription of ASA in primary prevention of CVD should be based on our evidence-based solution of weighing all the absolute benefits and risks rather than age. This strategy would do far more good for far more patients as well as far more good than harm in both developed and developing countries. This new and novel strategy for primary care providers to consider in prescribing ASA in primary prevention of CVD is the same as the general approach suggested by Professor Geoffrey Rose decades ago. |
format | Online Article Text |
id | pubmed-8710906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-87109062022-01-10 Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age Kim, Kyungmann Hennekens, Charles H Martinez, Lisa Gaziano, J Michael Pfeffer, Marc A Biglione, Bianca Gitin, Alexander McCabe, Jeanne Bell Cook, Thomas D DeMets, David L Wood, Sarah K Fam Med Community Health Perspective Recent guidelines restricted aspirin (ASA) in primary prevention of cardiovascular disease (CVD) to patients <70 years old and more recent guidance to <60. In the most comprehensive prior meta-analysis, the Antithrombotic Trialists Collaboration reported a significant 12% reduction in CVD with similar benefit−risk ratios at older ages. Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, four trials were added to an updated meta-analysis. ASA produced a statistically significant 13% reduction in CVD with 95% confidence limits (0.83 to 0.92) with similar benefits at older ages in each of the trials. Primary care providers should make individual decisions whether to prescribe ASA based on benefit−risk ratio, not simply age. When the absolute risk of CVD is >10%, benefits of ASA will generally outweigh risks of significant bleeding. ASA should be considered only after implementation of therapeutic lifestyle changes and other drugs of proven benefit such as statins, which are, at the very least, additive to ASA. Our perspective is that individual clinical judgements by primary care providers about prescription of ASA in primary prevention of CVD should be based on our evidence-based solution of weighing all the absolute benefits and risks rather than age. This strategy would do far more good for far more patients as well as far more good than harm in both developed and developing countries. This new and novel strategy for primary care providers to consider in prescribing ASA in primary prevention of CVD is the same as the general approach suggested by Professor Geoffrey Rose decades ago. BMJ Publishing Group 2021-12-24 /pmc/articles/PMC8710906/ /pubmed/34952844 http://dx.doi.org/10.1136/fmch-2021-001475 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Perspective Kim, Kyungmann Hennekens, Charles H Martinez, Lisa Gaziano, J Michael Pfeffer, Marc A Biglione, Bianca Gitin, Alexander McCabe, Jeanne Bell Cook, Thomas D DeMets, David L Wood, Sarah K Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age |
title | Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age |
title_full | Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age |
title_fullStr | Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age |
title_full_unstemmed | Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age |
title_short | Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age |
title_sort | primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710906/ https://www.ncbi.nlm.nih.gov/pubmed/34952844 http://dx.doi.org/10.1136/fmch-2021-001475 |
work_keys_str_mv | AT kimkyungmann primarycareprovidersshouldprescribeaspirintopreventcardiovasculardiseasebasedonbenefitriskrationotage AT hennekenscharlesh primarycareprovidersshouldprescribeaspirintopreventcardiovasculardiseasebasedonbenefitriskrationotage AT martinezlisa primarycareprovidersshouldprescribeaspirintopreventcardiovasculardiseasebasedonbenefitriskrationotage AT gazianojmichael primarycareprovidersshouldprescribeaspirintopreventcardiovasculardiseasebasedonbenefitriskrationotage AT pfeffermarca primarycareprovidersshouldprescribeaspirintopreventcardiovasculardiseasebasedonbenefitriskrationotage AT biglionebianca primarycareprovidersshouldprescribeaspirintopreventcardiovasculardiseasebasedonbenefitriskrationotage AT gitinalexander primarycareprovidersshouldprescribeaspirintopreventcardiovasculardiseasebasedonbenefitriskrationotage AT mccabejeannebell primarycareprovidersshouldprescribeaspirintopreventcardiovasculardiseasebasedonbenefitriskrationotage AT cookthomasd primarycareprovidersshouldprescribeaspirintopreventcardiovasculardiseasebasedonbenefitriskrationotage AT demetsdavidl primarycareprovidersshouldprescribeaspirintopreventcardiovasculardiseasebasedonbenefitriskrationotage AT woodsarahk primarycareprovidersshouldprescribeaspirintopreventcardiovasculardiseasebasedonbenefitriskrationotage |